PDCD1 and neoplasm: However, when the tumor-killing percentage dropped below 40% after 3–4 rounds of tumor stimulation, the CAR-T cells were in a terminally exhausted-like hypofunction state that could not be rescued by PD-1 antibody treatment (Figures S1I and S1J).